JPMORGAN CHASE & CO - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,608,083
+40.0%
60,215
+68.5%
0.00%
Q2 2023$2,576,421
-27.2%
35,734
-25.7%
0.00%
Q1 2023$3,537,000
+136253.1%
48,089
+23.8%
0.00%
Q4 2022$2,594
-99.9%
38,833
-3.2%
0.00%
Q3 2022$3,454,000
-2.1%
40,105
+1.4%
0.00%
Q2 2022$3,528,000
-24.5%
39,549
-4.8%
0.00%
-100.0%
Q1 2022$4,675,000
-24.2%
41,558
+4.1%
0.00%0.0%
Q4 2021$6,167,000
+10.5%
39,923
-0.4%
0.00%0.0%
Q3 2021$5,582,000
-25.4%
40,068
-29.7%
0.00%0.0%
Q2 2021$7,481,000
+8.1%
57,027
+25.6%
0.00%0.0%
Q1 2021$6,923,000
+41.1%
45,413
-7.9%
0.00%0.0%
Q4 2020$4,906,000
+12.1%
49,321
+8.0%
0.00%0.0%
Q3 2020$4,376,000
+71.3%
45,680
+100.1%
0.00%
Q2 2020$2,554,000
+41.5%
22,831
-8.0%
0.00%
Q1 2020$1,805,000
-82.3%
24,825
-74.5%
0.00%
-100.0%
Q4 2019$10,170,000
+10.3%
97,513
+5.3%
0.00%0.0%
Q3 2019$9,222,000
+246.7%
92,638
+297.0%
0.00%
+100.0%
Q2 2019$2,660,000
-13.0%
23,333
-4.0%
0.00%0.0%
Q1 2019$3,057,000
-67.6%
24,314
-65.1%
0.00%
-50.0%
Q4 2018$9,443,000
+15.8%
69,584
+134.2%
0.00%0.0%
Q3 2018$8,156,000
+339.0%
29,707
+231.2%
0.00%
Q2 2018$1,858,000
-44.1%
8,970
-55.4%
0.00%
-100.0%
Q1 2018$3,325,000
-43.7%
20,132
-53.3%
0.00%0.0%
Q4 2017$5,907,000
+179.6%
43,142
+175.2%
0.00%
Q3 2017$2,113,000
+142.6%
15,676
+118.5%
0.00%
Q2 2017$871,000
+38.9%
7,175
+21.1%
0.00%
Q1 2017$627,000
+364.4%
5,925
+344.8%
0.00%
Q4 2016$135,000
+187.2%
1,332
+187.7%
0.00%
Q3 2016$47,000
-89.9%
463
-88.1%
0.00%
Q2 2016$465,000
+511.8%
3,895
+449.4%
0.00%
Q1 2016$76,000
+590.9%
709
+609.0%
0.00%
Q4 2015$11,000
-98.8%
100
-99.4%
0.00%
Q4 2014$953,000
+100.2%
17,909
+63.1%
0.00%
Q3 2013$476,000
-37.5%
10,981
-46.0%
0.00%
Q2 2013$761,00020,3420.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders